In addition to well-established TRAIL-induced apoptotic signaling, increasing evidence has unraveled novel mechanisms that either promote or inhibit TRAIL-induced apoptosis in GBM (Figure 1), offering potential therapeutic targets for overcoming TRAIL resistance. The gene discussed is TNFSF10; the disease is glioblastoma.